EMC Capital Management - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 145 filers reported holding AMNEAL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
EMC Capital Management ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$171
+4.3%
40,613
+886.7%
0.13%
-0.8%
Q2 2023$164
+192.9%
4,116
-89.9%
0.13%
+170.2%
Q1 2023$56
-30.9%
40,6130.0%0.05%
-35.6%
Q4 2022$81
-99.9%
40,6130.0%0.07%
-3.9%
Q3 2022$82,000
-36.4%
40,6130.0%0.08%
-30.9%
Q2 2022$129,000
-17.3%
40,613
+0.5%
0.11%
-1.8%
Q1 2022$156,00040,4170.11%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$103,087,0005.89%
Eversept Partners, LP 6,440,572$30,850,3401.97%
TPG GP A, LLC 16,213,367$77,662,0000.78%
Signature Wealth Management Partners, LLC 87,666$420,0000.36%
Hedges Asset Management LLC 75,000$359,0000.28%
Hillsdale Investment Management Inc. 869,916$4,167,0000.28%
Tranquilli Financial Advisor LLC 71,414$342,0000.24%
HUSSMAN STRATEGIC ADVISORS, INC. 180,000$862,0000.19%
GLOBEFLEX CAPITAL L P 297,414$1,424,0000.15%
XTX Topco Ltd 23,742$114,0000.06%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders